The widely held belief that innovation is primarily driven by lone geniuses is being challenged by recent research highlighting the collaborative nature of major scientific and technological advances. Revisiting the history of penicillin, often attributed solely to Alexander Fleming, illustrates a broader narrative of cumulative teamwork and gradual development.

Fleming’s 1928 discovery of the antibacterial properties of penicillium mould marked an initial breakthrough, but it took several years and contributions from numerous scientists and pharmaceutical companies to develop the antibiotic into a life-saving drug. Notably, figures such as Cecil Paine—Fleming’s pupil—and Albert Alexander, the first patient treated with penicillin, are commemorated for their roles in refining and applying the drug. Mass production of penicillin was eventually achieved by Pfizer, underscoring the prolonged effort required beyond the original discovery.

This pattern of collective innovation extends beyond medicine. Historian Andrew Leigh, in his recent work, underscores how famous inventions like the electric lightbulb emerged from a series of improvements by multiple inventors before Thomas Edison perfected the product and introduced effective marketing. Edison’s Menlo Park laboratory exemplified how organized teams could accelerate invention, employing hundreds of people working toward incremental and major innovations.

Economic research supports the idea that innovation flourishes through collaborative environments that promote the free exchange of ideas and products. The 2025 Nobel Prize in Economics was awarded to economists studying “creative destruction,” the process by which continuous innovation drives long-term economic growth. Philippe Aghion, one of the laureates, emphasized the importance of balancing incentives for new ideas with regulation to prevent dominant companies from stifling competition.

Despite this understanding, recent data suggest that innovation activity in the United Kingdom is on the decline. Official statistics indicate that the proportion of UK firms engaged in developing new products or processes fell from 53 percent in 2014 to 34 percent in recent years. Experts argue that while innovation is often associated with private enterprise, government policies and support structures play a critical role in fostering environments conducive to innovation.

Studies of venture capital investments illustrate the unpredictable nature of backing innovation, with most start-ups failing to generate positive returns. However, a small number of highly successful companies account for the majority of gains, highlighting the challenges in identifying and supporting future breakthroughs.

Research consistently shows that innovation thrives in collaborative team settings rather than through isolated individual effort. Scientific progress often occurs through shared discussions and iterative development rather than sudden “eureka” moments. Furthermore, international trade and the exchange of goods and ideas are critical in spreading innovations, as exemplified by the global journey of Red Fife wheat, which transformed Canada’s agricultural capacity after seeds and expertise moved across continents.

The story of penicillin’s development serves as a reminder that groundbreaking discoveries typically require sustained, multi-faceted efforts involving many contributors over time. Creating conditions that support such collaborative innovation remains a key challenge for governments and industries alike.